Dossier
survival time
Coverage of survival time in the Nexus archive.
- 'Transformative' pancreatic cancer drug doubles survival time
An experimental daily pill for advanced pancreatic cancer nearly doubled survival time compared to chemotherapy infusions. Patients taking the drug lived significantly longer than those receiving traditional treatment.
- FDA expanding access to pancreatic cancer drug to some patients
The FDA announced it is expanding access to a pancreatic cancer drug that showed nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial. This decision aims to provide earlier access to the promising treatment.